Revised dose ramp-up to mitigate the risk of tumor lysis syndrome when initiating venetoclax in patients with mantle cell lymphoma

Matthew S. Davids, Gottfried Von Keudell, Craig A. Portell, Jonathon B. Cohen, David C. Fisher, Francine Foss, Andrew W. Roberts, John F. Seymour, Rod A. Humerickhouse, Constantine S. Tam

Research output: Contribution to journalLetterOtherpeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)3525-3527
Number of pages3
JournalJournal of Clinical Oncology
Issue number35
Publication statusPublished - 10 Dec 2018
Externally publishedYes

Cite this